Metformin, a well‐known AMPK agonist, has been widely used as the first‐line drug for
treating type 2 diabetes. There had been a significant concern regarding the use of …

Cardiac dysfunction is a common complication in patients with sepsis triggering high
morbidity and mortality. Lycorine (LYC), the main effective monomer component extracted …

Metformin can reduce cardiovascular risk independent of glycemic control. The mechanisms
behind its non-glycemic benefits, which include decreased energy intake, lower blood …

Purpose: To investigate the clinical efficacy and safety of combined Gegen Qinlian
decoction/metformin in the treatment of diabetes mellitus (DM), and its influence on serum C …

The search for new drugs with the potential to ensure therapeutic success in the treatment of
cardiovascular diseases has become an essential pathway to follow for health organizations …